Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3-Induced Myocarditis and Antiviral Drug Screening Platform

被引:114
|
作者
Sharma, Arun [1 ,2 ,3 ,4 ]
Marceau, Caleb [5 ]
Hamaguchi, Ryoko [1 ,2 ,3 ,4 ]
Burridge, Paul W. [1 ,2 ,3 ]
Rajarajan, Kuppusamy [1 ,2 ,3 ]
Churko, Jared M. [1 ,2 ,3 ]
Wu, Haodi [1 ,2 ,3 ]
Sallam, Karim I. [1 ,2 ,3 ]
Matsa, Elena [1 ,2 ,3 ]
Sturzu, Anthony C. [1 ,2 ,3 ]
Che, Yonglu [1 ,2 ,3 ]
Ebert, Antje [1 ,2 ,3 ]
Diecke, Sebastian [1 ,2 ,3 ]
Liang, Ping [1 ,2 ,3 ]
Red-Horse, Kristy [3 ,4 ]
Carette, Jan E. [5 ]
Wu, Sean M. [1 ,2 ,3 ]
Wu, Joseph C. [1 ,2 ,3 ,6 ]
机构
[1] Stanford Univ, Sch Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
myocarditis; myocytes; cardiac; stem cells; ADENOVIRUS-RECEPTOR; INTERFERON-BETA; INHIBITION; DIFFERENTIATION; REPLICATION; MECHANISMS; FLUOXETINE; EXPRESSION; MATURATION; INFECTION;
D O I
10.1161/CIRCRESAHA.115.303810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. A major causative agent for viral myocarditis is the B3 strain of coxsackievirus, a positive-sense RNA enterovirus. However, human cardiac tissues are difficult to procure in sufficient enough quantities for studying the mechanisms of cardiac-specific viral infection. Objective: This study examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced viral myocarditis and to screen antiviral therapeutics for efficacy. Methods and Results: hiPSC-CMs were infected with a luciferase-expressing coxsackievirus B3 strain (CVB3-Luc). Brightfield microscopy, immunofluorescence, and calcium imaging were used to characterize virally infected hiPSC-CMs for alterations in cellular morphology and calcium handling. Viral proliferation in hiPSC-CMs was quantified using bioluminescence imaging. Antiviral compounds including interferon beta 1, ribavirin, pyrrolidine dithiocarbamate, and fluoxetine were tested for their capacity to abrogate CVB3-Luc proliferation in hiPSC-CMs in vitro. The ability of these compounds to reduce CVB3-Luc proliferation in hiPSC-CMs was consistent with reported drug effects in previous studies. Mechanistic analyses via gene expression profiling of hiPSC-CMs infected with CVB3-Luc revealed an activation of viral RNA and protein clearance pathways after interferon beta 1 treatment. Conclusions: This study demonstrates that hiPSC-CMs express the coxsackievirus and adenovirus receptor, are susceptible to coxsackievirus infection, and can be used to predict antiviral drug efficacy. Our results suggest that the hiPSC-CM/CVB3-Luc assay is a sensitive platform that can screen novel antiviral therapeutics for their effectiveness in a high-throughput fashion.
引用
收藏
页码:556 / +
页数:34
相关论文
共 50 条
  • [41] Pharmacoelectrophysiology of Viral-Free Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes
    Mehta, Ashish
    Chung, YingYing
    Sequiera, Glen Lester
    Wong, Philip
    Liew, Reginald
    Shim, Winston
    TOXICOLOGICAL SCIENCES, 2013, 131 (02) : 458 - 469
  • [42] Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
    Yoshida, Shohei
    Miyagawa, Shigeru
    Fukushima, Satsuki
    Kawamura, Takuji
    Kashiyama, Noriyuki
    Ohashi, Fumiya
    Toyofuku, Toshihiko
    Toda, Koichi
    Sawa, Yoshiki
    MOLECULAR THERAPY, 2018, 26 (11) : 2681 - 2695
  • [43] Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
    Mummery, Christine L.
    STEM CELL REPORTS, 2018, 11 (06): : 1306 - 1311
  • [44] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    Podgurskaya, A. D.
    Slotvitsky, M. M.
    Tsvelaya, V. A.
    Frolova, S. R.
    Romanova, S. G.
    Balashov, V. A.
    Agladze, K. I.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Induced Pluripotent Stem Cell-Derived Cardiomyocytes Boutique Science or Valuable Arrhythmia Model?
    Knollmann, Bjoern C.
    CIRCULATION RESEARCH, 2013, 112 (06) : 969 - 976
  • [46] Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Yuecel, Goekhan
    Zhou, Xiaobo
    Terkatz, Linda
    Wendel, Angela
    Reinhardt, Julius
    El-Battrawy, Ibrahim
    Sattler, Katherine
    Cyganek, Lukas
    Utikal, Jochen
    Langer, Harald
    Scharf, Ruediger
    Duerschmied, Daniel
    Akin, Ibrahim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [47] Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease
    Tiwari, Satish Kumar
    Wong, Wei Jie
    Moreira, Marco
    Pasqualini, Claudia
    Ginhoux, Florent
    NATURE REVIEWS IMMUNOLOGY, 2025, 25 (02) : 108 - 124
  • [48] 3D Micropillars Guide the Mechanobiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Palankar, Raghavendra
    Glaubitz, Michael
    Martens, Ulrike
    Medvedev, Nikolay
    von der Ehe, Marvin
    Felix, Stephan B.
    Muenzenberg, Markus
    Delcea, Mihaela
    ADVANCED HEALTHCARE MATERIALS, 2016, 5 (03) : 335 - 341
  • [49] Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes
    Maas, Renee G. C.
    Lee, Soah
    Harakalova, Magdalena
    Blok, Christian J. B. Snijders
    Goodyer, William R.
    Hjortnaes, Jesper
    Doevendans, Pieter A. F. M.
    Van Laake, Linda W.
    van der Velden, Jolanda
    Asselbergs, Folkert W.
    Wu, Joseph C.
    Sluijter, Joost P. G.
    Wu, Sean M.
    Buikema, Jan W.
    STAR PROTOCOLS, 2021, 2 (01):
  • [50] Differentiation, Maintenance, and Contraction Profiling of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Snelders, Matthijs
    van der Pluijm, Ingrid
    Essers, Jeroen
    BIO-PROTOCOL, 2025, 15 (05):